Ironwood Pharmaceuticals, Inc. (IRWD)

Ironwood Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year	Current	2023	2022	2021	2020	2019
Market Capitalization	989	1,786	1,901	1,908	1,824	2,087
Market Cap Growth	-15.93%	-6.02%	-0.40%	4.64%	-12.64%	30.78%
Enterprise Value	1,558	2,410	1,659	1,764	1,925	2,364
PE Ratio	-	-1.78	10.86	3.61	17.17	97.06
PS Ratio	2.39	4.03	4.63	4.61	4.68	4.87
PB Ratio	-4.12	-5.16	2.91	3.15	29.11	-22.38
P/FCF Ratio	6.68	9.75	6.95	7.29	10.92	548.70
P/OCF Ratio	6.67	9.74	6.94	7.29	10.80	194.62
EV/Sales Ratio	3.77	5.44	4.04	4.26	4.94	5.52
EV/EBITDA Ratio	-1.98	-2.69	6.35	7.56	13.57	37.13
EV/EBIT Ratio	-1.97	-2.69	6.38	7.61	13.92	40.69
EV/FCF Ratio	10.53	13.16	6.06	6.74	11.53	621.57
Debt / Equity Ratio	-2.09	-2.07	0.64	0.79	7.44	-4.88
Debt / EBITDA Ratio	-0.71	-0.80	1.59	2.04	3.28	7.15
Debt / FCF Ratio	4.67	3.91	1.52	1.82	2.79	119.74
Quick Ratio	0.77	0.80	30.85	4.70	15.85	8.02
Current Ratio	0.83	0.85	30.58	4.61	15.41	7.50
Asset Turnover	0.81	0.64	0.39	0.43	0.82	1.21
Interest Coverage	-35.84	-41.48	34.22	7.44	4.69	1.59
Return on Equity (ROE)	312.70%	1300.10%	30.50%	116.90%	-1065.40%	-12.20%
Return on Assets (ROA)	-206.60%	-145.60%	16.70%	55.40%	22.40%	6.10%
Return on Capital (ROIC)	-276.32%	-256.05%	16.25%	56.48%	26.38%	33.16%
Earnings Yield	-106.41%	-56.11%	9.21%	27.69%	5.82%	1.03%
FCF Yield	14.96%	10.25%	14.40%	13.71%	9.16%	0.18%
Buyback Yield / Dilution	15.52%	16.57%	-13.32%	-2.34%	-2.97%	-2.22%
Total Shareholder Return	15.52%	16.57%	-13.32%	-2.34%	-2.97%	-2.22%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).